Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease

Abstract Breakdown of the neurovascular unit is associated with blood-brain barrier (BBB) leakiness contributing to cognitive decline and disease pathology in the early stages of Alzheimer’s disease (AD). Vascular stability depends on angiopoietin-1 (ANGPT-1) signalling, antagonised by angiopoietin-...

Full description

Bibliographic Details
Published in:	Translational Psychiatry
Main Authors:	Carol Van Hulle, Selvi Ince, Ozioma C. Okonkwo, Barbara B. Bendlin, Sterling C. Johnson, Cynthia M. Carlsson, Sanjay Asthana, Seth Love, Kaj Blennow, Henrik Zetterberg, J. Scott Miners
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-01-01
Online Access:	https://doi.org/10.1038/s41398-023-02706-w

Similar Items

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
by: Ruocheng Dong, et al.
Published: (2023-08-01)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
by: Ruocheng Dong, et al.
Published: (2021-01-01)

Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study
by: Mariana I. Muñoz-García, et al.
Published: (2025-10-01)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
by: Lena L. Law, et al.
Published: (2018-01-01)

Synaptic markers are associated with cognitive decline after accounting for amyloid burden among an at-risk Alzheimer’s disease cohort
by: Elizabeth M. Planalp, et al.
Published: (2025-06-01)

Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals
by: Henry Gilreath Stephenson, et al.
Published: (2025-01-01)

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline
by: Ajay Kumar Nair, et al.
Published: (2022-01-01)

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
by: J. S. Miners, et al.
Published: (2019-09-01)

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease
by: Anna Jeppsson, et al.
Published: (2022-03-01)

Repeated lumbar punctures within 3 days may affect CSF biomarker levels
by: Martin Olsson, et al.
Published: (2019-12-01)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
by: Andrew P. Merluzzi, et al.
Published: (2019-01-01)

Neurological assessment and its relationship to CSF biomarkers in amateur boxers.
by: Sanna Neselius, et al.
Published: (2014-01-01)

Cardiovascular rate pressure product is associated with NfL in older adults at risk for AD
by: Chinenye C. Odo, et al.
Published: (2025-01-01)

CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.
by: Sanna Neselius, et al.
Published: (2012-01-01)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
by: Yue Ma, et al.
Published: (2021-01-01)

Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics
by: Lorenzo Gaetani, et al.
Published: (2021-07-01)

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
by: Peder Buchhave, et al.
Published: (2009-01-01)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
by: Samantha L. Allison, et al.
Published: (2019-01-01)

Transient increase in CSF GAP-43 concentration after ischemic stroke
by: Åsa Sandelius, et al.
Published: (2018-12-01)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
by: Elena Camporesi, et al.
Published: (2021-02-01)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.
Published: (2013-01-01)

Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery
by: Majd Saadaldeen, et al.
Published: (2025-05-01)

Measuring longitudinal cognition: Individual tests versus composites
by: Erin M. Jonaitis, et al.
Published: (2019-12-01)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
by: Xiaofang Zhong, et al.
Published: (2019-01-01)

Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status
by: Rigina L. Gallagher, et al.
Published: (2023-10-01)

Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus
by: Rebecca Grønning, et al.
Published: (2023-10-01)

More fit KL‐VS heterozygotes have more favorable AD‐relevant biomarker profiles
by: Mackenzie Jarchow, et al.
Published: (2025-07-01)

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
by: Kristīne Ivanova, et al.
Published: (2024-08-01)

CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
by: Klaus Thanke Aspli, et al.
Published: (2023-10-01)

Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
by: Nazib M Seidu, et al.
Published: (2024-01-01)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
by: Igal Rosenstein, et al.
Published: (2022-08-01)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
by: Adam J Paulsen, et al.
Published: (2025-04-01)

Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
by: Thomas K. Karikari, et al.
Published: (2018-03-01)

Perioperative brain injury marker concentrations in neonatal open-heart surgery: a prospective observational study
by: Åsa Jungner, et al.
Published: (2023-08-01)

Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersResearch in context
by: Agathe Vrillon, et al.
Published: (2025-05-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
by: Julia Remnestål, et al.
Published: (2021-03-01)

Association between serum urate and CSF markers of Alzheimer's disease pathology in a population‐based sample of 70‐year‐olds
by: Tahzeeb Fatima, et al.
Published: (2021-01-01)

Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01)

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry
by: Elena Camporesi, et al.
Published: (2022-01-01)